Of Mites and Men: Trypsin-like Proteases in the Lungs

American Journal of Respiratory Cell and Molecular Biology

Volumn 16, Issue 6, 1997, Pages 621-628

  Caughey, George H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARI;

AUTACOID; CHYMASE; CHYMASE 2; KALLIKREIN; PLASMIN; SERINE PROTEINASE; TRYPSIN; TRYPTASE;

ANIMAL; CHEMISTRY; ENZYMOLOGY; HUMAN; LUNG; PHYSIOLOGY; REVIEW;

ANIMALS; CHYMASES; HUMANS; INFLAMMATION MEDIATORS; KALLIKREINS; LUNG; PLASMIN; SERINE ENDOPEPTIDASES; TRYPSIN; TRYPTASES;

EID: 0031157105     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.16.6.9191463     Document Type: Review

References (69)

1. Proud, D. 1993. Kinins and mast cell-related diseases. In The Mast Cell in Health and Disease. M. A. Kaliner and D. D. Metcalfe, editors. Marcel Dekker, New York. 415-441.
2. Polosa, R., and S. T. Holgate. 1990. Comparative airway responses to inhaled bradykinin, kallidin, and [des-Arg9] bradykinin in normal and asthmatic subjects. Am. Rev. Respir. Dis. 142:1367-1371.
3. Roisman, G. L., J. G. Lacronique, N. Nesmazes-Dufeu, C. Carre, A. L. Cae, and D. J. Dusser. 1996. Airway responsiveness to bradykinin is related to eosinophilic inflammation in asthma. Am. J. Respir. Crit. Care Med. 153: 381-390.
4. MacDonald, R. J., H. S. Margulis, and E. G. Erdos. 1988. Molecular biology of tissue kallikrein. Biochem. J. 253:313-321.
5. Proud, D., and C. P. Vio. 1993. Localization of immunoreactive tissue kallikrein in human trachea. Am. J. Respir. Cell Mol. Biol. 8:16-19.
6. Christiansen, S. C., D. Proud, R. B. Sarnoff, U. Juergens, C. G. Cochrane, and B. L. Zuraw. 1992. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am. Rev. Respir. Dis. 145:900-905.
7. Wenzel, S. E., A. D. Fowler, and L. B. Schwartz. 1988. Activation of pulmonary mast cells by bronchoalveolar allergen challenge: in vivo release of histamine and tryptase in atopic subjects with and without asthma. Am. Rev. Respir. Dis. 137:1002-1008.
8. Imamura, T., A. Dubin, W. Moore, R. Tanaka, and J. Travis. 1996. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab. Invest. 74:861-870.
9. Soler, M., M. Sielczac, and W. M. Abraham. 1990. A bradykinin antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. Pulm. Pharmacol. 3:9-15.
10. Slapke, J., S. Hummel, G. G. Wischnewsky, and J. Winkler. 1986. Protease inhibitor prevents bronchoconstriction in man. Eur. J. Respir. Dis. 68:29-34.
11. Misawa, M., K. Takenouchi, M. Sato, and S. Yanaura. 1987. The effect of trans-4-guanidinomethylcyclohexanecarboxylic acid p-tert-butylphenyl ester hydrochloride (NCO-650) on Ascaris suum antigen-induced bronchoconstriction in dogs. Japan. J. Pharmacol. 43:53-60.
12. Akagi, M., M. Mio, and K. Tasaka. 1983. Histamine release inhibition and prevention of the decrease in membrane fluidity by certain anti-allergic drugs: analysis of the inhibitor mechanism of NCO-650. Agents Actions 13:149-156.
13. Caughey, G. H., editor. 1995. Mast Cell Proteases in Immunology and Biology. Marcel Dekker, New York.
14. Miller, J. S., E. H. Westin, and L. B. Schwartz. 1989. Cloning and characterization of complementary DNA for human tryptase. J. Clin. Invest. 84: 1188-1195.
15. Vanderslice, P., S. M. Ballinger, E. K. Tam, S. M. Goldstein, C. S. Craik, and G. H. Caughey. 1990. Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc. Natl. Acad. Sci. USA 87:3811-3815.
16. Tam, E. K., and G. H. Caughey. 1990. Degradation of airway neuropeptides by human lung tryptase. Am. J. Respir. Cell Mol. Biol. 3:27-32.
17. Lilly, C. M., L. Kobzik, A. E. Hall, and J. M. Drazen. 1994. Effects of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs. J. Clin. Invest. 93:2667-2674.
18. Sekizawa, K., G. H. Caughey, S. C. Lazarus, W. M. Gold, and J. A. Nadel. 1989. Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs. J. Clin. Invest. 83:175-179.
19. Johnson, P. R. A., A. J. Ammit, S. M. Carlin, C. L. Armour, G. H. Caughey, and J. L. Black. 1997. Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus. Eur. Respir. J. (In press)
20. Ruoss, S. J., T. Hartmann, and G. H. Caughey. 1991. Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 88:493-499.
21. Brown, J. K., C. L. Tyler, C. A. Jones, S. J. Ruoss, T. Hartmann, and G. H. Caughey. 1995. Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13:227-236.
22. Cairns, J. A., and A. F. Walls. 1996. Mast cell tryptase is a mitogen for epithelial cells - stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J. Immunol. 156:275-283.
23. Clark, J. M., W. M. Abraham, C. E. Fishman, R. Forteza, A. Ahmed, A. Cortes, R. L. Warne, W. R. Moore, and R. D. Tanaka. 1995. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am. J. Respir. Crit. Care Med. 152:2076-2083.
24. Caughey, G. H., W. W. Raymond, E. Bacci, R. J. Lombardy, and R. R. Tidwel. 1993. Bis(5-amidino-2-benzimidazolyl) methane and related amidines are potent, reversible inhibitors of mast cell tryptases. J. Pharmacol. Exp. Therap. 264:676-682.
25. Robinson, T., K. Delaria, P. Harris, D. Lindell, R. Gundel, and D. Muller. 1996. Secretory leukocyte protease inhibitor as an inhibitor of mast cell tryptase. Am. J. Respir. Crit. Can Med. 153:A399. (Abstr.)
26. Sanctis, G. T. D., M. Merchant, D. R. Beier, R. D. Dredge, J. K. Grohholz, T. R. Martin, E. S. Lander, and J. M. Drazen. 1995. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nature Genetics 11:150-154.
27. Ghildyal, N., D. S. Friend, R. Freelund, K. F. Austen, H. P. McNeil, V. Schiller, and R. L. Stevens. 1994. Lack of expression of the tryptase mouse mast cell protease 7 in mast cells of the C57BL/6J mouse. J. Immunol. 153:2624-2630.
28. Hunt, J. E., R. L. Stevens, K. F. Austen, J. Zhang, Z. N. Xia, and N. Ghildyal. 1996. Natural disruption of the mouse mast cell protease 7 gene in the C57BL/6 mouse. J. Biol. Chem. 271:2851-2855.
29. Chua, K. Y., G. A. Stewart, W. R. Thomas, R. J. Simpson, R. J. Dilworth, T. M. Plozza, and K. J. Turner. 1988. Sequence analysis of cDNA coding for a major house dust mite allergen. Der p 1. Homology with cysteine proteases. J. Exp. Med. 167:175-182.
30. Stewart, G. A., L. D. Ward, R. J. Simpson, and P. J. Thompson. 1992. The group III allergen from house mite Dermatophagoides pteronyssinus is a trypsin-like enzyme. Immunology 75:29-35.
31. Nishiyama, C., T. Yasuhara, T. Yuuki, and Y. Okumura. 1995. Cloning and expression in Escherichia coli of cDNA encoding house dust mite allergen Der f 3, serine protease from Dermatophagoides farinae. FEBS Lett. 377: 62-66.
32. Maruo, K., T. Akaike, Y. Inada, I. Ohkubo, T. Ono, and H. Maeda. 1993. Effect of microbial and mite proteases on low and high molecular weight kininogens. J. Biol. Chem. 268:17711-17715.
33. Tovey, E. R., M. D. Chapman, and T. A. E. Platts-Mills. 1981. Mite faeces are a major source of house dust allergens. Nature 289:592-593.
34. Herbert, C. A., C. M. King, P. C. Ring, S. T. Holgate, G. A. Stewart, P. J. Thompson, and C. Robinson. 1995. Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p1. Am. J. Respir. Cell Mol. Biol. 12:369-378.
35. Hewitt, C. R. A., A. P. Brown, B. J. Hart, and D. I. Pritchard. 1995. A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection hy antiproteases. J. Exp. Med. 182:1537-1544.
36. Davis, P. B. 1995. Intruder in the dust: why are dust mites such effective allergens? Am. J. Respir. Cell Mol. Biol. 12:367-368.
37. Furie, B., and B. C. Furie. 1988. The molecular basis of blood coagulation. Cell 53:505-518.
38. McDonald, J. A. 1990. The yin and yang of fibrin in the airways. N. Engl. J. Med. 322:929-931.
39. McNamara, C. A., I. J. Saremhock, L. W. Gimple, J. W. Fenton, II, S. R. Coughlin, and G. K. Owens. 1993. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 91:94-98.
40. Vu, T.-K. H., D. T. Hung, V. I. Wheaton, and S. R. Coughlin. 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.
41. Sitrin, R. G. 1992. Plasminogen activation in the injured lung: pulmonology does not recapitulate hematology. Am. J. Respir. Cell Biol. 6:131-132.
42. Bertozzi, P., B. Astedt, L. Zenzius, K. Lynch, F. LeMaire, W. Zapol, and H. A. Chapman, Jr. 1990. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N. Engl. J. Med. 322:890-897.
43. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degan, R. Bronson, R. D. Vos, J. J. vd Oord, D. Collen, and R. C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-124.
44. Takahashi, K., T. Kiguchi, Y. Sawasaki, F. Karikusa, N. Nemoto, T. Matsuoka, and M. Yamamoto. 1992. Lung capillary endothelial cells produce and secrete urokinase-type plasminogen activator. Am. J. Respir. Cell Mol. Biol. 7:90-94.
45. Marshall, B. C. D. S. Sageser, N. V. Rao, M. Emi, and J. R. Hoidal. 1990. Alveolar epithelial cell plasminogen activator: characterization and regulation. J. Biol. Chem. 265:8198-8204.
46. Vassalli, J. D. 1994. The urokinase receptor. Fibrinolysis 8(Suppl. 1):172-181.
47. Stefansson, S., and D. A. Lawrence. 1996. The serpin PAI-1 inhibits cell migratlion by blocking integrin avb3 binding to vitronectin. Nature 383:441-443.
48. Gyetko, M. R., G.-H. Chen, R. A. McDonald, R. Goodman, G. B. Huffnagle, C. C. Wilkinson, J. A. Fuller, and G. B. Toews. 1996. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: a murine transgenic model. J. Clin. Invest. 97:1818-1826.
49. Stack, M. S., and D. A. Johnson. 1994. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J. Biol. Chem. 269:9416-9419.
50. Garten, W., F. X. Bosch, D. Linder, R. Rott, and H.-D. Klenk. 1981. Proteolytic activation of the influenza virus hemagglutinin: the structure of the cleavage site and the enzymes involved in cleavage. Virology 115:361-374.
51. Barbey-Morel, C. L., T. N. Oeltmann, K. M. Edwards, and P. F. Wright. 1982. Role of respiratory tract proteases in infectivity of influenza A virus. J. Infect. Dis. 155:667-672.
52. Tashiro, M., P. Ciborowski, H. D. Klenk, G. Pulverer, and R. Rott. 1987. Role of Staphylococcus protease in the development of influenza pneumonia. Nature 325:536-537.
53. Kido, H., Y. Yokogoshi, K. Sakai, M. Tashiro, Y. Kishino, A. Fukutomi, and N. Katunuma. 1992. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells: a possible activator of the viral fusion glycoprotein. J. Biol. Chem. 267:13573-13579.
54. Sakai, K., T. Kohri, M. Tashiro, Y. Kishino, and H. Kido. 1994. Sendai virus infection changes the subcellular localization of tryptase Clara in rat bronchiolar epithelial cells. Eur. Respir. J. 7:686-692.
55. Tidwell, R. R., J. D. Geratz, W. A. Clyde, K. U. Rosenthal, and E. J. Dubovi. 1984. Suppression of respiratory syncytial virus infection in cotton rats by bis(5-amidino-2-benzimidazolyl)methane. Antimicrob. Agents Chemother. 26: 591-593.
56. Gershenfeld, H. K., and I. L. Weissman. 1986. Cloning of a cDNA for a T cell-specific serine protease from a cytotoxic T lymphocyte. Science 232: 854-858.
57. Masson, D., and J. Tschopp. 1987. A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell 49:679-685.
58. Caughey, G. H. 1994. Serine proteases of mast cell and leukocyte granules: a league of their own. Am. J. Respir. Crit. Care Med. 150:S138-S142.
59. Quan, L. T., M. Tewari, K. O'Rourke, V. Dixit, S. J. Snipas, G. G. Poirier, C. Ray, D. J. Pickup, and G. S. Salvesen. 1996. Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc. Natl. Acad. Sci. USA 93:1972-1976.
60. Talento, A., M. Nguyen, S. Law, J. K. Wu, M. Poe, J. T. Blako, M. Patel, T. J. Wu, T. L. Manyak, M. Silberklang, G. Mark, M. Springer, N. H. Sigal, I. L. Weissman, R. C. Bleackley, E. R. Podack, M. L. Tykocinski, and G. C. Koo. 1992. Transfection of mouse cytotoxic T lymphocyte with an antisense granzyme A vector reduces lytic activity. J. Immunol. 149:4009-4015.
61. Ebnet, K., M. Hausmann, F. Lehmann-Grube, A. Mullbacher, M. Kopf, M. Lamers, and M. M. Simon. 1995. Granzyme A-deficient mice retain potent cell-mediated toxicity. EMBO J. 14:4230-4239.
62. Mullbacher, A., K. Ebnet, R. V. Blanden, R. T. Hla, T. Stehle, C. Museteanu, and M. M. Simon. 1996. Granzyme A is critical tor recovery from in fection with the natural cytopathic viral pathogen, ectromelia. Proc. Natl. Acad Sci. USA 93:5783-5787.
63. Sower, L. E., C. J. Froelich, N. Allegretto, P. M. Rose, W. D. Hanna, and G. R. Kumpel. 1996. Extracellular activities of human granzyme A - monocyte activation by granzyme A versus alpha-thrombin. J. Immunol. 156:2585-2590.
64. Savers, T. J., I. A. Wiltrout, M. J. Smyth, K. S. Ottaway, A. M. Pilaro, R. Sowder, L. E. Henderson, M. Sprenger, and A. R. Lloyd. 1994. Purification and cloning of a novel serine protease, RNK-Tryp-2, from the granules of a rat NK cell leukemia. J. Immunol. 152:2289-2297.
65. Frank, M. M. 1987. Complement in the pathophysiology of human disease. N. Engl. J. Med. 316:1525-1530.
66. Kam, C.-M., B. J. McRae, J. W. Harper, M. A. Niemann, J. F. Volanakis, and J. C. Powers. 1987. Human complement proteins D. C2 and B. Active site mapping with peptide thioester substrates. J. Biol. Chem. 262:3444 3451.
67. Cook, K. S., D. L. Groves, H. Y. Min, and B. M. Spiegelman. 1985. A developmentally regulated mRNA from 3T3 adipocytes encodes a novel serine protease homologue. Proc. Natl. Acad. Sci. USA 82:6480-6484.
68. White, E. T., D. Damm, N. Hancock, B. S. Rosen, B. B. Lowell, P. Usher, J. S. Flier, and B. S. Spiegelman. 1992. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J. Biol. Chem. 267:9210-9213.
69. Zhu, L., D. Wigle, A. Hinek, J. Kobayashi, C. Ye, M. Zuker, H. Dodo, F. W. Keeley, and M. Rabinovitch. 1994. The endogenous vascular elastase that governs development and progression of monocrotoline-induced pulmonary hypertension in rats is a novel enzyme related to the serine protease adipsin. J. Clin. Invest. 94:1163-1171.